Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
Fierce Biotech
As measles surges, the first treatment remains a pipe dream
Measles drug development is fraught with challenges, and there are no approved drugs for the disease or any being tested in clinical trials.
Darren Incorvaia
Jul 17, 2025 2:02pm
Fierce Biotech
Federal judge rules hundreds of NIH grant terminations unlawful
Jun 16, 2025 5:55pm
Fierce Biotech
NIH staff urge director to reverse funding cuts, firings
Jun 9, 2025 4:33pm